West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,500 | 84,300 | 62,700 | 87,200 | 102,500 |
| Marketable Securities | N/A | 2,600 | 2,900 | N/A | 6,000 |
| Receivables | 142,500 | 143,400 | 137,200 | 128,600 | 140,600 |
| Inventories | 135,900 | 130,000 | 120,000 | 115,700 | 124,700 |
| Income taxes - deferred | 4,400 | 4,300 | 3,900 | 5,100 | 5,400 |
| Other current assets | 36,800 | 31,600 | 29,500 | 29,600 | 31,300 |
| TOTAL | $399,100 | $396,200 | $356,200 | $366,200 | $410,500 |
| Non-Current Assets | |||||
| PPE Net | 570,400 | 548,000 | 517,700 | 531,000 | 518,600 |
| Investments And Advances | 35,800 | 34,400 | 36,400 | 33,600 | 34,100 |
| Intangibles | 171,700 | 154,200 | 152,000 | 155,300 | 154,700 |
| Other Non-Current Assets | 86,900 | 84,700 | 79,200 | 82,600 | 92,100 |
| TOTAL | $864,800 | $821,300 | $785,300 | $802,500 | $799,500 |
| Total Assets | $1,263,900 | $1,217,500 | $1,141,500 | $1,168,700 | $1,210,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 55,300 | 60,700 | 52,000 | 67,600 | 61,700 |
| Accrued Expenses | 53,200 | 44,800 | 39,600 | 45,900 | 48,200 |
| Other current liabilities | 33,400 | 36,900 | 30,000 | 34,700 | 33,700 |
| TOTAL | $162,800 | $161,500 | $138,700 | $159,100 | $165,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 393,000 | 386,300 | 384,000 | 382,100 | 382,000 |
| aiOther Non-Current Liabilities | 120,200 | 113,500 | 110,400 | 120,000 | 84,100 |
| TOTAL | $535,400 | $523,000 | $514,200 | $522,500 | $511,900 |
| Total Liabilities | $698,200 | $684,500 | $652,900 | $681,600 | $677,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,002 | 65,781 | 65,517 | 65,472 | 65,432 |
| Common Shares | 8,600 | 8,600 | 8,600 | 8,600 | 8,600 |
| Retained earnings | 559,600 | 542,400 | 527,700 | 517,300 | 504,500 |
| Other shareholders' equity | -19,400 | -31,300 | -56,000 | -45,100 | 17,500 |
| TOTAL | $565,700 | $533,000 | $488,600 | $487,100 | $532,600 |
| Total Liabilities And Equity | $1,263,900 | $1,217,500 | $1,141,500 | $1,168,700 | $1,210,000 |